Sandbox Reserved 1095

From Proteopedia

(Difference between revisions)

Revision as of 15:31, 10 January 2020

This Sandbox is Reserved from 25/11/2019, through 30/9/2020 for use in the course "Structural Biology" taught by Bruno Kieffer at the University of Strasbourg, ESBS. This reservation includes Sandbox Reserved 1091 through Sandbox Reserved 1115.

To get started:

Click the edit this page tab at the top. Save the page after each step, then edit it again.
show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Human Angiotensin Receptor

Angiotensin receptors belongs to the G protein coupled receptor (GPCR). It is a membrane protein located mainly in heart, brain, liver and kidneys.

1 Function
2 History
3 Structure (function relationship)
4 Application in the therapeutic field

Function

History

Searchers suspected since 70s the existence of different angiotensin receptors. But it was only at the end of 80s that searchers had tools to identify these two distinct trans-membrane receptors (AT1R and AT2R) ^[1]. Three labs discovered in the same time these two receptors so they were some confusion about the nomenclature. So in 1991 a group of searchers met in Baltimore under the presidency of Merlin Bumpus to define a coherent nomenclature. Finally, around 2015, researchers found the crystal structure of the receptor in complex with its antagonist ZD7155 and with an inverse agonist olmesartan ^[2]. They used x-ray cryogenic-crystallography. They found similar conformation of the receptor when it is linked to the antagonist or to the inverse agonist. They also found conserved molecular recognition modes. So to complete the discovery, they realized some experiments with mutants to identify the different residues which interact with the ligand.

Structure (function relationship)

Primary and secondary structure

Humman angiotensin receptor consists in a 376 amino acid string ^[3].

Ligand binding pocket

Interaction with drugs

Olmesartan, candesartan, telmisartan, and valsartan

Olmesartan anchored to ATR1 by the residues , and . Those amino acids seem to play an important role in the binding of the drug to AT1R, thanks to the formation of extensive networks of hydrogen bonds and salt bridges with the ligand ^[4].

Many drugs used to cure diseases linked with the angiotensin receptor contain a tetrazole group. Studies showed that the tetrazole plays an important role in the binding with AT1R.

Lys199 : an important role for AngII binding

Interaction with other GPCRs

It has been showed that AT1Rs were also able to bind with other GPCRs to form homo- or heterodimers. Those interactions can modify the sensitivity of the receptor, which leads to different physiological and pathological conditions than the GPCR monomer ^[5] ^[6].

Application in the therapeutic field

Since angiotensin receptor is involved in the renin-angiotenisin system, it represents a target of choice to cure some diseases like hypertension or heart failure. An over-stimulation of this receptor seems to be involved in hypertension, coronary artery disease, cardiac hypertrophy, heart failure, arrhythmia, strocke, diabetic nephropathy and ischemic heart and renal diseases ^[7].

Several anti-hypertensive drugs are targeting the angiotensin receptor in order to block it. This is the case for drugs called angiotensin receptor blockers (ARBs) like olmesartan or candesartan. One of the common characteristic they share is their biphenyl-tetrazole scaffold.

References

This is a sample scene created with SAT to by Group, and another to make of the protein. You can make your own scenes on SAT starting from scratch or loading and editing one of these sample scenes.

Retrieved from "http://52.214.119.220/wiki/index.php/Sandbox_Reserved_1095"

@@ Line 8: / Line 8: @@
 == History ==
-Searchers suspected since 70s the existence of different angiotensin receptors. But it was only at the end of 80s that searchers had tools to identify these two distinct trans-membrane receptors (AT1R and AT2R)<ref>https://www.researchgate.net/profile/Marc_De_Gasparo/publication/238340301_Les_rcepteurs_AT1_et_AT2_de_langiotensine_II_Lessentiel/links/567d3a9308aebccc4e03e6df.pdf  </ref>. Three labs discovered in the same time these two receptors so they were some confusion about the nomenclature. So in 1991 a group of searchers met in Baltimore under the presidency of  Merlin Bumpus to define a coherent nomenclature. Finally, around 2015, researchers  found the crystal structure of the receptor in complex with its antagonist ZD7155 and with an inverse agonist olmesartan <ref> https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705918/ </ref>. They used x-ray cryogenic-crystallography. They found similar conformation of the receptor when it is linked to the antagonist or to the inverse agonist. They also found conserved molecular recognition modes. So to complete the discovery, they realized some experiments with mutants to identify the different residues which interact with the ligand.
+Searchers suspected since 70s the existence of different angiotensin receptors. But it was only at the end of 80s that searchers had tools to identify these two distinct trans-membrane receptors (AT1R and AT2R) <ref>https://www.researchgate.net/profile/Marc_De_Gasparo/publication/238340301_Les_rcepteurs_AT1_et_AT2_de_langiotensine_II_Lessentiel/links/567d3a9308aebccc4e03e6df.pdf  </ref>. Three labs discovered in the same time these two receptors so they were some confusion about the nomenclature. So in 1991 a group of searchers met in Baltimore under the presidency of  Merlin Bumpus to define a coherent nomenclature. Finally, around 2015, researchers  found the crystal structure of the receptor in complex with its antagonist ZD7155 and with an inverse agonist olmesartan <ref> https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4705918/ </ref>. They used x-ray cryogenic-crystallography. They found similar conformation of the receptor when it is linked to the antagonist or to the inverse agonist. They also found conserved molecular recognition modes. So to complete the discovery, they realized some experiments with mutants to identify the different residues which interact with the ligand.
 == Structure (function relationship) ==
@@ Line 19: / Line 19: @@
 === Interaction with drugs ===
 ====Olmesartan, candesartan, telmisartan, and valsartan====
-Olmesartan anchored to ATR1 by the residues Tyr35, Trp84<scene name='82/829348/Trp84/2'>Text To Be Displayed</scene> and Arg167.
+Olmesartan anchored to ATR1 by the residues <scene name='82/829348/Tyr35/5'>Tyr35</scene>, <scene name='82/829348/Trp84/4'>Trp84</scene> and <scene name='82/829348/Arg167/2'>Arg167</scene>.
 Those amino acids seem to play an important role in the binding of the drug to AT1R, thanks to the formation of extensive networks of hydrogen bonds and salt bridges with the ligand <ref> http://www.jbc.org/content/290/49/29127 </ref>.
@@ Line 25: / Line 26: @@
 Lys199 : an important role for AngII binding
 ==== Interaction with other GPCRs====